MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CURX — Curanex Pharmaceuticals Inc Common Stock
NasdaqCuranex Pharmaceuticals Inc Common Stock
$4.72
-0.25(-5.03%)
- O
- 4.70
- H
- 5.10
- L
- 4.59
- V
- 2.69K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CURX
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateAug 26, 2025
Employees6
Stock ExchangeNasdaq
Ticker SymbolCURX
Key Financial Statistics
| Market Cap | $7.40M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.18 - $6.80 |
| 52-Week Avg Volume | 1.22M |
| VWAP | $4.77 |
| Transactions | 211 |
| Total Recorded Bars | 278 days |